With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD & Dipak Panigrahy, MD||Innovation Grants||2015||Massachusetts|
|Therapeutic Reactivation of p53 to Overcome Apoptotic Resistance in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD, PhD & Kimberly Stegmaier, MD||Reach Grants||2015||Massachusetts|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|
|The Role of ARID1A in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Hui Shi, PhD||Young Investigator Grants||2016||Massachusetts|
|Resistance and Develop Improved Treatments for Relapsed/refractory Pediatric ALL||Dana-Farber Cancer Institute / Elizabeth Townsend, PhD||Young Investigator Grants||2016||Massachusetts|
|Web-Based Cognitive-Behavioral Treatment for Insomnia in Adolescent Cancer Survivors||Dana-Farber Cancer Institute / Eric Zhou, PhD||Psychosocial Grants||2016||Massachusetts|
|Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions||Dana-Farber Cancer Institute / Cecile Rouleau, PhD||Young Investigator Grants||2017||Massachusetts|
|Targeting BRD9 in Sarcoma||Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD||Innovation Grants||2017||Massachusetts|
|Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma||Dana-Farber Cancer Institute / Cigall Kadoch, PhD||'A' Award Grants||2017||Massachusetts|
|Novel Approaches to AML Differentiation Therapy||Dana-Farber Cancer Institute / Andrew Lane, MD/PhD||'A' Award Grants||2017||Massachusetts|